Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked: The altitude survival by rhythm study

Journal of the American College of Cardiology

Volumn 62, Issue 18, 2013, Pages 1674-1679

  Powell, Brian D ^a   Saxon, Leslie A ^b   Boehmer, John P ^c   Day, John D ^d   Gilliam III, F Roosevelt ^e   Heidenreich, Paul A ^f   Jones, Paul W ^g   Rousseau, Matthew J ^g   Hayes, David L ^h  

^a Sanger Heart and Vascular Institute   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d INTERMOUNTAIN MEDICAL CENTER   (United States)

^e Cardiology Associates of Northeast Arkansas   (United States)

^f VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^g Biostatistics Department   (United States)

^h MAYO CLINIC   (United States)

Author keywords

atrial fibrillation; cardiac resynchronization therapy; implantable cardioverter defibrillators; ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SIGNAL NOISE RATIO; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; SURVIVAL PREDICTION; SURVIVAL RATE;

AF; AFL; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR; CI; CONFIDENCE INTERVAL; CRT-D; HAZARD RATIO; HR; ICD; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; MONOMORPHIC VENTRICULAR TACHYCARDIA; MVT; PMVT; POLYMORPHIC VENTRICULAR TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; SVT; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; VF; VT;

ARRHYTHMIAS, CARDIAC; ARTIFACTS; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDIES; TELEMETRY;

EID: 84886409725     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.083     Document Type: Article

References (21)

1. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
3. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. J.P. Daubert, W. Zareba, and D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
5. J.E. Poole, G.W. Johnson, and A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
6. L.A. Saxon, D.L. Hayes, and F.R. Gilliam Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study Circulation 122 2010 2359 2367
7. F.R. Gilliam, D.L. Hayes, and J.P. Boehmer Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study J Cardiovasc Electrophysiol 22 2011 1023 1029
8. B.D. Powell, Y.M. Cha, and S.J. Asirvatham Implantable cardioverter defibrillator electrogram adjudication for device registries: methodology and observations from ALTITUDE Pacing Clin Electrophysiol 34 2011 1003 1012
9. G.P. Walcott, C.R. Killingsworth, and R.E. Ideker Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction? Resuscitation 59 2003 59 70
10. T. Schluter, H. Baum, A. Plewan, and D. Neumeier Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage Clin Chem 47 2001 459 463
11. K.M. Stein, R.B. Devereux, and R.T. Hahn Effect of transthoracic shocks on left ventricular function Resuscitation 66 2005 309 315
12. A.J. Moss, C. Schuger, and C.A. Beck Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
13. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades Eur Heart J 27 2006 936 941
14. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
15. D.A. Cesario, B. Powell, and M. Cao Atrial fibrillation and outcomes in a large cohort of CRT recipients: results from the ALTITUDE study J Am Coll Cardiol 57 Suppl S 2011 E153
16. S.E. Mountantonakis, M.V. Grau-Sepulveda, D.L. Bhatt, A.F. Hernandez, E.D. Peterson, and G.C. Fonarow Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure Circ Heart Fail 5 2012 191 201
17. M.O. Sweeney, L. Sherfesee, P.J. DeGroot, M.S. Wathen, and B.L. Wilkoff Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients Heart Rhythm 7 2010 353 360
18. G.K. Larsen, J. Evans, W.E. Lambert, Y. Chen, and M.H. Raitt Shocks burden and increased mortality in implantable cardioverter-defibrillator patients Heart Rhythm 8 2011 1881 1886
19. M.S. Wathen, M.O. Sweeney, and P.J. DeGroot Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease Circulation 104 2001 796 801
20. J.B. van Rees, C.J. Borleffs, and M.K. de Bie Inappropriate implantable cardioverter-defibrillator shocks incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
21. S.P. Bhavnani, J. Kluger, and C.I. Coleman The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators Heart Rhythm 7 2010 755 760